Addus Homecare (Nasdaq: ADUS) expects to achieve 5% to 7% hospice growth during 2025. The company’s hospice business is emerging from the shadow of the pandemic, which hurt that business segment considerably more than it did Addus’ home health and personal care service lines. Early and sudden deaths among COVID patients significantly reduced national hospice […]
Addus HomeCare Corporation’s (Nasdaq: ADUS) purchase of Gentiva’s personal care segment is bearing fruit as the company drives forward on its acquisition strategy in 2025. But labor constraints and evolving reimbursement pressures could complicate the growth of its hospice and home-based services. The Texas-headquartered personal care, home health and hospice provider is narrowing its strategic […]
Hospice News explores the issues garnering growing attention in end-of-life care delivery in seven of this year’s “hidden gem” stories. Topics span trends related to program integrity, workforce development, health equity, service diversification and the keys to hospices’ growth strategies. Hospice Investors to Watch Hospice merger and acquisition (M&A) activity has seen a cooling period […]
Gentiva has filed a lawsuit against Bristol Hospice alleging that a former employee violated agreements with the company, including those for noncompetition and confidentiality. The company filed the suit in a federal court in Maine. Gentiva alleges that a registered nurse administrator disclosed trade secrets after leaving the company and securing employment with Bristol. The […]
Valuations in the hospice space have led Addus Homecare (Nasdaq: ADUS) to take a more conservative approach to hospice transactions as it actively seeks home health and personal care deals. Hospice multiples reach record highs in 2020 and 2021, as much as 26x. Since then the price tags have reportedly come down, but they haven’t […]
Addus HomeCare Corporation (Nasdaq: ADUS) may slow down on mergers and acquisitions in the near term as it absorbs Gentiva’s personal care business. The Texas-headquartered personal care, home health and hospice provider is taking a “conservative approach” to its merger and acquisition strategies, said Addus CEO and Chairman Dirk Allison in an earnings call on […]
Gentiva in 2024 and 2025 is laser-focused on staff retention and building out its advanced illness management platform Illumia Health. Workforce shortages have plagued the hospice community for years, along with the health care sector at large. This has led to a sharpened focus among many providers on hiring and keeping employees, particularly when it […]
Strategic priorities for Texas-headquartered Addus HomeCare Corporation (NASDAQ: ADUS) continue to focus on personal care and home health and less on hospice as the company waits for the dust to settle following its Gentiva personal care acquisition. Improvements in hospice valuation trends have not come far enough in recent years to make the market a […]
Gentiva has agreed to pay $19.4 million to resolve False Claims Act complaints that predate the company’s acquisition of Kindred at Home. The U.S. Justice Department alleges that Kindred at Home and related entities knowingly submitted false claims and retained overpayments for hospice services provided to patients who were ineligible. The federal government and the […]
VITAS Healthcare Expands Hospital-Based Inpatient Hospice Center Chemed Corp. (NYSE: CHE) VITAS Healthcare recently expanded its inpatient hospice care unit at the Florida-based Broward Health Medical Center. The inpatient facility now has 12 patient beds, up from eight prior to the renovations. VITAS expects to serve roughly 550 patients annually at the center. “VITAS is […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
